Shanks JH - Search Results

1

Parathyroid hormone-related peptide: expression in prostate cancer bone metastases.

Bryden AA, Islam S, Freemont AJ, Shanks JH, George NJ, Clarke NW. Bryden AA, et al. Among authors: shanks jh. Prostate Cancer Prostatic Dis. 2002;5(1):59-62. doi: 10.1038/sj.pcan.4500553. Prostate Cancer Prostatic Dis. 2002. PMID: 15195132

2

Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion.

Scott LJ, Clarke NW, George NJ, Shanks JH, Testa NG, Lang SH. Scott LJ, et al. Among authors: shanks jh. Br J Cancer. 2001 May 18;84(10):1417-23. doi: 10.1054/bjoc.2001.1804. Br J Cancer. 2001. PMID: 11355957 Free PMC article.

3

Biomolecular profiling of metastatic prostate cancer cells in bone marrow tissue using FTIR microspectroscopy: a pilot study.

Gazi E, Dwyer J, Lockyer NP, Gardner P, Shanks JH, Roulson J, Hart CA, Clarke NW, Brown MD. Gazi E, et al. Among authors: shanks jh. Anal Bioanal Chem. 2007 Mar;387(5):1621-31. doi: 10.1007/s00216-006-1093-y. Epub 2007 Feb 1. Anal Bioanal Chem. 2007. PMID: 17268776

4

FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer.

Baker MJ, Gazi E, Brown MD, Shanks JH, Gardner P, Clarke NW. Baker MJ, et al. Among authors: shanks jh. Br J Cancer. 2008 Dec 2;99(11):1859-66. doi: 10.1038/sj.bjc.6604753. Epub 2008 Nov 4. Br J Cancer. 2008. PMID: 18985044 Free PMC article.

5

A correlation of FTIR spectra derived from prostate cancer biopsies with gleason grade and tumour stage.

Gazi E, Baker M, Dwyer J, Lockyer NP, Gardner P, Shanks JH, Reeve RS, Hart CA, Clarke NW, Brown MD. Gazi E, et al. Among authors: shanks jh. Eur Urol. 2006 Oct;50(4):750-60; discussion 760-1. doi: 10.1016/j.eururo.2006.03.031. Epub 2006 Mar 31. Eur Urol. 2006. PMID: 16632188

6

Angiotropic lymphoma with endocrine involvement.

Shanks JH, Harris M, Howat AJ, Freemont AJ. Shanks JH, et al. Histopathology. 1997 Aug;31(2):161-6. doi: 10.1046/j.1365-2559.1997.2260835.x. Histopathology. 1997. PMID: 9279568

7

Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study.

Gazi E, Dwyer J, Gardner P, Ghanbari-Siahkali A, Wade AP, Miyan J, Lockyer NP, Vickerman JC, Clarke NW, Shanks JH, Scott LJ, Hart CA, Brown M. Gazi E, et al. Among authors: shanks jh. J Pathol. 2003 Sep;201(1):99-108. doi: 10.1002/path.1421. J Pathol. 2003. PMID: 12950022

8

Investigating FTIR based histopathology for the diagnosis of prostate cancer.

Baker MJ, Gazi E, Brown MD, Shanks JH, Clarke NW, Gardner P. Baker MJ, et al. Among authors: shanks jh. J Biophotonics. 2009 Feb;2(1-2):104-13. doi: 10.1002/jbio.200810062. J Biophotonics. 2009. PMID: 19343689

9

Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer.

Sachdeva A, Hart CA, Kim K, Tawadros T, Oliveira P, Shanks J, Brown M, Clarke N. Sachdeva A, et al. Br J Cancer. 2022 Oct;127(7):1254-1262. doi: 10.1038/s41416-022-01914-3. Epub 2022 Jul 22. Br J Cancer. 2022. PMID: 35869144 Free PMC article.

10

Should centralized histopathological review in penile cancer be the global standard?

Tang V, Clarke L, Gall Z, Shanks JH, Nonaka D, Parr NJ, Elliott PA, Clarke NW, Ramani V, Lau MW, Sangar VK. Tang V, et al. Among authors: shanks jh. BJU Int. 2014 Sep;114(3):340-3. doi: 10.1111/bju.12449. Epub 2014 Jan 15. BJU Int. 2014. PMID: 24053106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters